^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
OncoMate™ MSI

Company:
Promega
Type:
CE Marked
Related tests:

Details

Evidence
The OncoMate™ MSI Dx Analysis System is a CE-marked IVD medical device that uses a fluorescent PCR-based assay as part of a broader laboratory workflow to analyze formalin-fixed, paraffin-embedded (FFPE) tissue samples for microsatellite instability (MSI). It involves DNA extraction from FFPE tissue sample, quantification of DNA, amplification of specific microsatellite markers via multiplex PCR, analysis of amplified DNA fragments by capillary electrophoresis and analysis of capillary electrophoresis fragment data using a fragment analysis software.
Cancer:
Solid Tumor
Gene:
MSI (Microsatellite instability)
Drug:
Zynyz (retifanlimab-dlwr)
Method:
Multiplex-PCR
Approvals
Date
Cancer
Gene
Drug
By
06/09/20
CE